Remove Magnetic Resonance Imaging Remove MRI Remove Pharmaceutical
article thumbnail

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

Imaging Technology

mmol/kg gadobutrol (Gadavist) focused on adult patients referred for contrast-enhanced MRI of certain body regions. Of note, gadopiclenol was approved for both MRI of the central nervous system and of the body at the dose of 0.05 This multinational, crossover (within-patient), double-blind comparison of the safety and efficacy of 0.05

MRI 98
article thumbnail

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

Imaging Technology

Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., according to a written statement announcing the appointment. “I

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided Biopsy Using Local Anesthesia.